Business Standard

Warren Buffett's Berkshire Hathaway buys Teva, sells 94% of its IBM stake

Berkshire also nearly completed its yearlong exit from International Business Machines Corp (IBM), selling more than 94 per cent

Berkshire Hathaway CEO  Warren Buffet
Premium

Berkshire Hathaway CEO Warren Buffet

Reuters
Warren Buffett’s Berkshire Hathaway on Wednesday disclosed a new stake in drugmaker Teva Pharmaceutical Industries Ltd and said it bought more shares of Apple, which surpassed Wells Fargo & Co as its largest common stock investment.

Berkshire also nearly completed its yearlong exit from International Business Machines Corp (IBM), selling more than 94 per cent.

In a filing detailing its US-listed stock holdings, Berkshire reported owning about 18.9 million Teva American depositary receipts, worth about $358 million. Teva shares rose more than 10 per cent after market hours, reflecting what investors perceive as Berkshire’s seal of approval for the drugmaker. Berkshire said

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in